Nxera Pharma Co., Ltd.
4565.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥4,838 | -¥7,193 | ¥1,078 | ¥433 |
| Dep. & Amort. | ¥3,984 | ¥2,478 | ¥1,345 | ¥1,278 |
| Deferred Tax | ¥0 | -¥1,051 | ¥0 | ¥2,647 |
| Stock-Based Comp. | ¥1,396 | ¥870 | ¥700 | ¥713 |
| Change in WC | -¥7,078 | ¥1,609 | ¥5,258 | -¥1,783 |
| Other Non-Cash | -¥1,182 | -¥1,986 | ¥1,571 | ¥3,807 |
| Operating Cash Flow | -¥7,718 | -¥5,273 | ¥9,952 | ¥7,095 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥526 | -¥851 | -¥303 | -¥201 |
| Net Acquisitions | ¥379 | -¥62,941 | ¥137 | ¥206 |
| Inv. Purchases | ¥0 | ¥0 | -¥137 | -¥206 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥1,209 | ¥206 |
| Other Inv. Act. | -¥4,616 | ¥1 | ¥137 | ¥273 |
| Investing Cash Flow | -¥4,763 | -¥63,791 | ¥1,043 | ¥278 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥6,852 | ¥70,158 | ¥0 | ¥10,897 |
| Stock Issued | ¥0 | ¥9,983 | ¥0 | ¥600 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | -¥2 | -¥31,812 | -¥4,887 | -¥374 |
| Financing Cash Flow | -¥6,854 | ¥48,329 | -¥4,887 | ¥11,123 |
| Forex Effect | ¥2,538 | ¥3,243 | ¥362 | ¥1,583 |
| Net Chg. in Cash | -¥16,797 | -¥17,492 | ¥6,470 | ¥20,079 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥49,065 | ¥66,557 | ¥60,087 | ¥40,008 |
| End Cash | ¥32,268 | ¥49,065 | ¥66,557 | ¥60,087 |
| Free Cash Flow | -¥8,244 | -¥6,124 | ¥9,649 | ¥6,894 |